About: Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 24 May 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2018 (uk) im Mai 2018 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2018 (fr) artículu científicu espublizáu en mayu de 2018 (ast) scientific article published on 24 May 2018 (en)
publication date	wds:Q58486098-D2F1AEF6-9688-455F-AFC1-1F5FC4B99AA4
publication date	2018-05-24 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58486098-A022BACC-8599-4C42-A99E-F7B4D460417F
language of work or name	English
cites work	wds:Q58486098-0467E14C-9283-4936-9EE9-2C364487A03A wds:Q58486098-10478F9A-308F-4E41-A024-1D24A7BBB82C wds:Q58486098-104D0AE4-C2FD-42F6-9020-32C6A154FD8B wds:Q58486098-145D41C7-8673-4FED-99EB-53CAB5A4EA57 wds:Q58486098-1AC14B11-30C2-4A23-9754-23883CE897BB wds:Q58486098-243C14E4-2092-4DBB-B600-6FE1200ABE90 wds:Q58486098-30B7B34E-3293-4ADA-A726-BCD468E537BB wds:Q58486098-368C0A32-A9B8-4683-940C-F8B14D8C7497 wds:Q58486098-3A3E1E02-3ABC-48E9-9EE9-8F835FDE2C38 wds:Q58486098-3F1FBC0F-2AEA-4B4C-9239-65A5AAFD694A wds:Q58486098-43F33C28-4A16-4EA2-8C87-65EF8F7A68C8 wds:Q58486098-55F0B7E9-98B3-4281-91AD-C2564C29524A wds:Q58486098-5BABD866-8660-4B4F-8261-9772C47B3B80 wds:Q58486098-5D3ACF0C-093E-4508-9C5C-19BDA14813FB wds:Q58486098-68BCCBF1-DC85-4D01-834A-E6D7B94371D1 wds:Q58486098-71470DC5-7521-4F62-8ED6-65BEEDF2360A wds:Q58486098-73134346-7FEC-4E9C-B247-3CD01C9EC6E7 wds:Q58486098-8C45C3B0-D50F-4EBC-B468-BBFBF5B4BB5B wds:Q58486098-97E0CBB2-08BB-4229-ADFF-55BC48FE3948 wds:Q58486098-99F3B104-D3C0-4506-AAEB-83A3CC0F507C wds:Q58486098-9E514242-317F-4E1A-9760-9C0DFAC5AB3D wds:Q58486098-B34412DD-5C19-4995-A70E-CD5A64DBA6A5 wds:Q58486098-BD26D498-94F6-43A3-AF67-7D9CC096CFDB wds:Q58486098-C13AB4BB-762E-4B55-B7E6-AF4FF137B30C wds:Q58486098-C60A5E3D-48B3-47A4-A7B6-386E887C787A wds:Q58486098-CA7807EB-716B-4D3B-A0D2-299EFF2661BB wds:Q58486098-E00D6FF6-E7EE-413F-BF0F-62A97A122819 wds:Q58486098-EF8A79C6-B3D5-41AC-988F-711419964627 wds:Q58486098-F9375389-BED1-4507-A59B-52D37FE8A459 wds:Q58486098-FB650A75-14E3-4B94-844D-EFEA320C1159 wds:Q58486098-FEE2239A-DB67-45CD-B3C9-6B29E1AC1B47
cites work	Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma? Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of P Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86 Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group. High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumou
author name string	wds:Q58486098-0C7980E2-9CBF-4A83-A02E-92BF7416407A wds:Q58486098-169D3282-7F4A-493E-BF90-A57B9CC2E98D wds:Q58486098-1AF9724A-4A76-4F30-A34E-F08834F39003 wds:Q58486098-1CE27E93-0FAB-42FF-AE95-28DDD033B939 wds:Q58486098-568FB92D-9DFD-482B-9F04-E2812087AC34 wds:Q58486098-666AFD37-B55A-491E-8BF9-15F94E5C8068 wds:Q58486098-6852B797-AB16-45FA-9CBF-C6233FCB296E wds:Q58486098-8FD00934-98C6-4207-8041-67F4EB779A5E wds:Q58486098-9CE425F3-7772-4F79-B17E-477048998E1B wds:Q58486098-9E0C4D7C-5D94-4DC5-B6A8-C30C0C729A1D wds:Q58486098-ADEE9C92-12CC-4111-BF1B-30F2F5144FEC wds:Q58486098-C849F470-D7DF-4701-9E2E-7872C2C681DC
author name string	Timothy Rogers Peter Mudry Daniel Orbach Dominique Ranchère Angelica Zin Sima Ferman Christophe Bergeron Heidi Glosli Meriel Jenney Ilaria Zanetti Julia Chisholm European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
rdfs:label	Fusion status in patients with lymph node-positive (nl) Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (en)
skos:prefLabel	Fusion status in patients with lymph node-positive (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software